Diclofenac sodium is used to reduce pain, swelling, and inflammation from conditions like arthritis, menstrual cramps, and injuries. It works by blocking pain signals and reducing inflammation in the body.[2] Voltaren is currently approved and in use across 35 indications[4].[1]
Voltaren is one of 624 small molecule programs targeting Blood Coagulation Disease. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2828 competitors in Breast Cancer
Voltaren
Tykerb
Adriamycin
Avastin
Prolia
Gemzar
Lexiscan
Adenocard
Sporanox
QS21
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources
Details